MYRIAD GENETICS INC.

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

29 أغسطس 2024 13:31:27 بحسب NetDania Notify

Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

21 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

06 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific

01 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer

31 يوليو 2024 08:50:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

30 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

24 يوليو 2024 10:17:07 بحسب NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

23 يوليو 2024 10:02:36 بحسب NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

22 يوليو 2024 13:44:46 بحسب NetDania Notify

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

17 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

16 يوليو 2024 09:46:09 بحسب NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

15 يوليو 2024 09:45:02 بحسب NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

12 يوليو 2024 10:20:55 بحسب NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

11 يوليو 2024 13:01:36 بحسب NetDania Notify

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

11 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

09 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Earns 2024 Great Place To Work® Certification™

02 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

24 يونيو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

11 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

04 يونيو 2024 09:00:00 بحسب Nasdaq GlobeNewswire